This GSMR result possibly suggests that there is a switch of cellular function from OAS1-ACSL1 pathways in healthy individuals, as characterised by our metabolomic signatures in NFBC cohorts to OAS1-ACSL6 related severity pathways in COVID-19. The gene discussed is ACSL6; the disease is COVID-19.